ROLE OF NARINGENIN ON THE ANTIBACTERIAL ACTIVITY OF SELECTED β-LACTAM ANTIBIOTICS
Loading...
![Thumbnail Image](assets/images/Item.jpg)
Files
Date
2022-03
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
SRI VENKATESWARA VETERINARY UNIVERSITY TIRUPATI - 517 502. (A.P.) INDIA
Abstract
Beta-lactam antibiotics are one of the most commonly used antibacterial agents
against different bacterial infections in livestock. Among them ampicillin and amoxicillin
are most widely used by the clinicians in both human and veterinary practice. However,
their indiscriminate usage resulted in their reduced efficacy and development of
resistance by microorganisms.
To combat the resistance and restore the antibacterial efficacy of the antibiotics,
their combination with non antibiotic drugs like phytochemicals is being considered
actively.In the present study the drug interaction between selected β-lactam antibiotics
(ampicillin and amoxicillin) and phytochemical naringenin was evaluated against
Escherichia coli and Staphylococcus aureus invitro using micro broth dilution method,
crystal violet assay and checker board method.
MIC, MBC, FIC, and biofilm inhibition values were used as indicators to
determine the antibacterial activity.
MIC values of ampicillin, amoxicillin and naringenin against Escherichia coli
were 6.25μg/ml, 12.5μg/ml and 2.5mg/ml respectively. The minimum inhibitory
concentration values of ampicillin, amoxicillin and naringenin against Staphylococcus
aureus were 0.312μg/ml and 0.312μg/ml and 0.625mg/ml respectively. The MIC values
of ampicillin and amoxicillin were reduced by 2-fold in the presence of naringenin.
The MBC values of ampicillin were significantly reduced from 25μg/ml to
12.5μg/ml in presence of naringenin against Escherichia coli and from 1.25μg/ml to 0.625
μg/ml against Staphylococcus aureus. FIC value of combination of ampicillin with
naringenin against Escherichia coli and Staphylococcus aureus was 1 indicating the
additive effect of the combination.
The MBC values of amoxicillin were significantly reduced from 50μg/ml to
25μg/ml in presence of naringenin against Escherichia coli and from 1.25μg/ml to 0.625
μg/ml against Staphylococcus aureus. FIC value of combination of amoxicillin with
naringenin against Escherichia coli and Staphylococcus aureus was 1 indicating the
additive effect of the combination.
Ampicillin, amoxicillin and naringenin alone inhibited the Escherichia coli
biofilm formation by 63.5±2.25, 65.1±2.32 and 46.6±5.32 % respectively and
combination of ampicillin with naringenin and amoxicillin with naringenin inhibited the
biofilm formation by 44.3±2.89 and 54.4±2.68 % respectively.
xvi
Ampicillin, amoxicillin and naringenin alone inhibited the Staphylococcus aureus
biofilm formation by 59.3±2.28, 59.7±2.41 and 33.02±6.8 % respectively and
combination of ampicillin with naringenin and amoxicillin with naringenin inhibited the
biofilm formation by 32.65±3.49 and 45.9±2.31% respectively.
Based on the above results, it can be concluded that naringenin produced positive
drug interaction with ampicillin and amoxicillin by reduction in the MIC and MBC values
significantly. Further, in-vivo studies are required to establish antibacterial mechanism
and biofilm inhibition mechanisms of naringenin to develop it into a therapeutic agent
against infectious diseases.
Description
THESES